Novel coronavirus（SARS-CoV-2）Neutralizing Antibody Detection Kit (ELISA)
Basic Information
- Primary DI
- 06974593880100
- Basic UDI-DI Code
- B-06974593880100
- Reference
- NAD01
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Shanghai GeneoDx Biotech Co., Ltd.
Additional Description
The kit uses enzyme-linked immunosorbent assay (ELISA) to quantify detection or qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum/plasma samples. SARS-CoV-2 is a kind of new β-type coronavirus with envelope outside and particle in round or oval shape. It includes spike protein (S), envelope protein (E), membrane protein (M) and nucleocapsid protein (N). The spike protein (S) contains the receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor angiotensin converting enzyme 2 (ACE2), causing virus replication in the host cell by endocytosis. And the SARS-CoV-2 infection triggers an immune response to produce binding antibodies. The binding antibodies that can block the cell infiltration and replication of the virus are called neutralizing antibodies.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0105040699 | VIRAL ANTIGEN/ANTIBODY DETECTION - OTHER |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).